Sarah Henic

Sarah Henic has a diverse work experience in marketing and management roles. Sarah is currently the Head of Global Commercial Marketing and Planning at Abivax since June 2023. Prior to that, they worked as the Director of Marketing at Cerevel Therapeutics, where they led the go-to-market strategy for the Emraclidine product. Before that, they served as the Director of Global Marketing - IBD at Arena Pharmaceuticals, Inc. from November 2019 to June 2022. Sarah also worked as the Consumer Lead for Motegrity (prucalopride) at Takeda from January 2018 to November 2019.

Earlier in their career, Sarah held several roles at Shire, including Associate Director - Launch Lead and Senior Product Manager in the Gastrointestinal / Internal Medicine Business Unit. Sarah has also worked at Philips in various marketing and product management roles, such as Senior Manager, Field Marketing Analytics, and Senior Product Manager, Medical Consumables & Sensors.

Sarah's career began at Deloitte Consulting as a Business Analyst and Consultant, focusing on the Life Sciences and Healthcare practice. Sarah also had a brief stint at Accenture as an Analyst in the Retail Supply Chain practice. Sarah holds an MBA with a concentration in Health Sector Management from Boston University.

Sarah Henic completed their education with an MBA degree in Health Sector Management from the Questrom School of Business at Boston University between 2007 and 2009. Prior to that, they obtained a bachelor's degree in Finance and Operations Management from Boston College, which they completed from 2001 to 2005. Additionally, Sarah Henic obtained a certification in Coaching Skills for Leaders and Managers from LinkedIn in 2021.